Thursday, July 30th 2020 at 11:00am UTC Leading institutional investors commit $320 million through a common stock private investment in…
Thursday, July 30th 2020 at 11:00am UTC Leading institutional investors commit $320 million through a common stock private investment in…
Wednesday, August 5th 2020 at 11:05am UTC Contribution totalling Cdn$4.75 Million will support Phase 1 clinical development and manufacturing of…
Monday, July 27th 2020 at 12:00pm UTC Financing led by Frazier Healthcare Partners with Participation from OrbiMed and New Enterprise…
Tuesday, July 28th 2020 at 11:00am UTC Up to $13.3M funding to accelerate development and early clinical testing of antibodies…
Tuesday, July 28th 2020 at 10:30am UTC Participation from top-tier healthcare investors recognizes momentum across breadth of its CNS therapeutics…
Friday, July 24th 2020 at 3:23pm UTC HOUSTON–(BUSINESS WIRE)– Tvardi Therapeutics Inc. (“Tvardi”), a privately held, clinical-stage biopharmaceutical company focused…
Tuesday, July 28th 2020 at 8:00am UTC Financing co-led by seed investor Sofinnova Partners and incoming investor AbbVie, with additional…
Thursday, July 16th 2020 at 1:00pm UTC Appoints CEO, CFO, EVP of Operations, and SVP of Commercial Development NASHVILLE, Tenn.–(BUSINESS…
Thursday, July 23rd 2020 at 3:05am UTC VICTORIA, British Columbia–(BUSINESS WIRE)– Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) (TSX:AUP) (“Aurinia” or the “Company”),…